efgartigimod

Heavy! The world's first FcRn antagonist was approved by the FDA

The U.S. Food and Drug Administration (FDA) has approved efgartigimod (Vyvgart, argenx) for the treatment of acetylcholine receptors (...).

efgartigimod fcrn fda Myasthenia gravis

12-21